Dietary Phenolic Compounds as Anticancer Natural Drugs: Recent Update on Molecular Mechanisms and Clinical Trials

Saad Bakrim1, Nasreddine El Omari2, Naoufal El Hachlafi3

  • 1Geo-Bio-Environment Engineering and Innovation Laboratory, Molecular Engineering, Biotechnology, and Innovation Team, Polydisciplinary Faculty of Taroudant, Ibn Zohr University, Agadir 80000, Morocco.

Foods (Basel, Switzerland)
|November 11, 2022
PubMed

Insights

Dietary phenolic compounds from medicinal plants show significant anti-cancer effects by inducing apoptosis and inhibiting angiogenesis. Clinical studies support their therapeutic potential alone or with chemotherapy, offering promising cancer protective strategies.

Area of Science:

  • Oncology
  • Pharmacology
  • Nutritional Science

Background:

  • Chemotherapeutic drug development faces limitations due to poor selectivity and side effects.
  • Natural bioactive compounds, especially dietary phenolics, are increasingly recognized for cancer prevention and treatment.
  • Phenolic compounds possess functional groups enabling diverse anti-cancer mechanisms.

Purpose of the Study:

  • To explore the anti-cancer mechanisms of phenolic compounds found in food medicinal plants.
  • To review clinical trial evidence on the efficacy of these phenolic compounds.
  • To highlight advancements in understanding their therapeutic potential.

Main Methods:

  • Review of existing literature on phenolic compounds' anti-cancer properties.
  • Analysis of in vitro and in vivo studies detailing molecular mechanisms.
  • Examination of clinical trial data on phenolic compound efficacy.

Main Results:

  • Phenolics induce apoptosis, autophagy, and cell cycle arrest, and inhibit telomerase.
  • In vivo studies demonstrate anti-angiogenic and anti-invasion effects.
  • Clinical trials show efficacy of certain phenolics, alone or combined with chemotherapy.

Conclusions:

  • Phenolic compounds from medicinal plants offer multifaceted anti-cancer strategies.
  • Evidence supports their role in cancer therapy and prevention.
  • Further research and clinical application of these natural compounds are warranted.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K